PAYO vs. CLOV
PAYO (Payoneer Global Inc.) and CLOV (Clover Health Investments, Corp.) are both stocks. PAYO operates in Software - Infrastructure (Technology), while CLOV operates in Healthcare Plans (Healthcare). Over the past 3 years, PAYO returned 13.31%/yr vs 66.22%/yr for CLOV. At a 0.37 correlation, their price movements are largely independent.
Performance
PAYO vs. CLOV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PAYO achieves a 20.11% return, which is significantly lower than CLOV's 101.28% return.
PAYO
- 1D
- 0.00%
- 1M
- 36.92%
- YTD
- 20.11%
- 6M
- 13.26%
- 1Y
- -2.17%
- 3Y*
- 13.31%
- 5Y*
- —
- 10Y*
- —
CLOV
- 1D
- -3.47%
- 1M
- 33.24%
- YTD
- 101.28%
- 6M
- 75.19%
- 1Y
- 61.43%
- 3Y*
- 66.22%
- 5Y*
- -20.64%
- 10Y*
- —
PAYO vs. CLOV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
PAYO Payoneer Global Inc. | 20.11% | -44.02% | 92.71% | -4.75% | -25.58% | -34.08% |
CLOV Clover Health Investments, Corp. | 101.28% | -25.40% | 230.85% | 2.43% | -75.01% | -71.32% |
Correlation
The correlation between PAYO and CLOV is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jun 28, 2021 | 0.37 |
The correlation between PAYO and CLOV shifts across timeframes, from 0.26 (3 years) to 0.37 (all time), reflecting how their relationship changes across market environments.
Fundamentals
PAYO:
$2.37B
CLOV:
$2.47B
PAYO:
$0.20
CLOV:
-$0.11
PAYO:
2.33
CLOV:
1.10
PAYO:
3.59
CLOV:
7.28
PAYO:
$1.07B
CLOV:
$2.21B
PAYO:
$660.73M
CLOV:
$939.14M
PAYO:
$204.88M
CLOV:
-$55.21M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PAYO vs. CLOV — Risk / Return Rank
PAYO
CLOV
PAYO vs. CLOV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Payoneer Global Inc. (PAYO) and Clover Health Investments, Corp. (CLOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PAYO | CLOV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.91 | ||
| Sortino ratioReturn per unit of downside risk | -1.28 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.20 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | -0.05 | 1.11 | -1.16 |
| Martin ratioReturn relative to average drawdown | -0.09 | 2.02 | -2.11 |
Loading charts...
Drawdowns
PAYO vs. CLOV - Drawdown Comparison
The maximum PAYO drawdown since its inception was -69.06%, smaller than the maximum CLOV drawdown of -97.19%. Use the drawdown chart below to compare losses from any high point for PAYO and CLOV.
Loading charts...
Drawdown Indicators
| PAYO | CLOV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.06% | -97.19% | +28.13% |
Max Drawdown (1Y)Largest decline over 1 year | -42.45% | -55.50% | +13.05% |
Max Drawdown (3Y)Largest decline over 3 years | -61.36% | -64.73% | +3.37% |
Max Drawdown (5Y)Largest decline over 5 years | — | -95.76% | — |
Current DrawdownCurrent decline from peak | -39.46% | -78.65% | +39.19% |
Average DrawdownAverage peak-to-trough decline | -43.06% | -76.59% | +33.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.76% | 30.46% | -6.70% |
Volatility
PAYO vs. CLOV - Volatility Comparison
The current volatility for Payoneer Global Inc. (PAYO) is 24.55%, while Clover Health Investments, Corp. (CLOV) has a volatility of 26.03%. This indicates that PAYO experiences smaller price fluctuations and is considered to be less risky than CLOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PAYO | CLOV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 24.55% | 26.03% | -1.48% |
Volatility (6M)Calculated over the trailing 6-month period | 43.67% | 43.15% | +0.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 53.15% | 71.33% | -18.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 56.64% | 77.38% | -20.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 56.64% | 85.80% | -29.16% |
Dividends
PAYO vs. CLOV - Dividend Comparison
Neither PAYO nor CLOV has paid dividends to shareholders.
Financials
PAYO vs. CLOV - Financials Comparison
This section allows you to compare key financial metrics between Payoneer Global Inc. and Clover Health Investments, Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PAYO vs. CLOV - Profitability Comparison
PAYO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Payoneer Global Inc. reported a gross profit of 0.00 and revenue of 261.60M. Therefore, the gross margin over that period was 0.0%.
CLOV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a gross profit of 692.13M and revenue of 749.19M. Therefore, the gross margin over that period was 92.4%.
PAYO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Payoneer Global Inc. reported an operating income of 30.02M and revenue of 261.60M, resulting in an operating margin of 11.5%.
CLOV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported an operating income of 27.33M and revenue of 749.19M, resulting in an operating margin of 3.7%.
PAYO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Payoneer Global Inc. reported a net income of 19.57M and revenue of 261.60M, resulting in a net margin of 7.5%.
CLOV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a net income of 27.33M and revenue of 749.19M, resulting in a net margin of 3.7%.
Frequently Asked Questions
PAYO and CLOV have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLOV has higher volatility (26.03%) compared to PAYO (24.55%). In terms of maximum drawdown, PAYO dropped -69.06% vs CLOV's -97.19%.
CLOV currently has the higher Sharpe Ratio (0.87 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PAYO and CLOV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer